Carregant...
Molecular diagnostics of lung cancer in the clinic
According to current practice guidelines, all patients with advanced non-small cell lung cancer (NSCLC) should undergo predictive biomarker testing. For squamous cell carcinoma patients, PD-L1 immunohistochemistry is indicated to select patients for immunotherapy in the first line. For lung adenocar...
Guardat en:
| Publicat a: | Transl Lung Cancer Res |
|---|---|
| Autor principal: | |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
AME Publishing Company
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5653520/ https://ncbi.nlm.nih.gov/pubmed/29114472 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr.2017.08.03 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|